Back to Results
First PageMeta Content
Cash flow / Generally Accepted Accounting Principles / Financial statements / Cash flow statement / Financial services / Funds / Microbicides for sexually transmitted diseases / Docetaxel / Operating cash flow / Finance / Accountancy / Business


Quarterly Cashflow Report Melbourne, Australia; 28 January 2015: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today released its Appendix 4C – Quarterly Cashflow report for the period ended 31 December[removed]The c
Add to Reading List

Document Date: 2015-01-27 18:08:03

Open Document

File Size: 322,29 KB

Share Result on Facebook

City

Melbourne / /

Company

Melbourne Australia / Ansell Limited / Lilly / AstraZeneca / Okamoto Industries / Starpharma Holdings Ltd / /

Continent

Asia / /

Country

Mexico / New Zealand / Japan / United States / Australia / China / /

Currency

USD / /

/

Event

Business Partnership / /

Holiday

New Year's Day / /

IndustryTerm

dendrimer products / retail outlets / bank / pharmaceutical and medical uses / agrochemical products / /

MarketIndex

ASX 300 / /

MedicalCondition

bacterial vaginosis / important cancer / neutropenia / tumour / recurrent bacterial vaginosis / /

MedicalTreatment

dendrimer / dendrimers / /

MusicAlbum

Asia / /

Organization

FDA / European Union / /

Person

Jackie Fairley / Adama / Rebecca Wilson Mob / Gabriella Hold / Nigel Baade / /

/

Position

general public pricing pressures / Chief Executive Officer / CFO and Company Secretary / Secretary / market leader / leader in the development / leader / /

Product

VivaGel / Taxotere / /

Technology

pharmacokinetics / drug delivery / /

URL

www.starpharma.com / /

SocialTag